BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership393,895 shares
Latest Disclosed Value $ 22,251,128
Citigroup Inc ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 393,895 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $22,251,129 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 176,226 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 123.52% during the quarter. The current value of the position is $21,530,301 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 30,000 of underlying shares valued at $1,694,700 USD and put options representing 30,000 of underlying shares valued at $1,694,700 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 393,895 217,669 123.52 22,251 112.46 0.0095
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 176,226 1,551 0.89 10,473 10.71 0.0046
2025-11-10 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 174,675 -6,298 -3.48 9,460 -4.91 0.0042
2025-08-11 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 180,973 -88,094 -32.74 9,948 -47.70 0.0049
2025-05-12 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 269,067 50,613 23.17 19,020 32.47 0.0097
2025-02-12 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 218,454 11,254 5.43 14,359 -1.41 0.0085
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 207,200 37,517 22.11 14,564 4.25 0.0084
2024-08-12 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 169,683 -52,691 -23.69 13,970 -28.07 0.0089
2024-05-10 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 222,374 31,582 16.55 19,422 5.58 0.0128
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 190,792 -18,316 -8.76 18,396 -0.57 0.0130
2023-12-06 2023-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 209,108 -7,746 -3.57 18,502 -1.57 0.0138
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 209,108 -7,746 18,502 0.0055
2023-08-10 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 216,854 -52,752 -19.57 18,797 -28.30 0.0123
2023-05-11 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 269,606 90,762 50.75 26,216 41.65 0.0184
2023-02-09 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 178,844 -33,171 -15.65 18,509 2.98 0.0147
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 212,015 32,579 18.16 17,973 20.88 0.0129
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 179,436 58,316 48.15 14,869 59.23 0.0111
2022-05-12 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 121,120 -194,424 -61.62 9,338 -66.50 0.0057
2022-02-10 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 315,544 76,314 31.90 27,878 50.77 0.0149
2021-11-10 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 239,230 -14,603 -5.75 18,491 -12.69 0.0109
2021-08-10 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 253,833 -7,177 -2.75 21,179 7.46 0.0127
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 261,010 29,854 12.92 19,709 -2.77 0.0127
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 231,156 -28,807 -11.08 20,271 2.50 0.0120
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 259,963 -5,204 -1.96 19,776 -39.53 0.0129
2020-08-12 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 265,167 25,653 10.71 32,706 61.60 0.0255
2020-05-12 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 239,514 1,540 0.65 20,239 0.59 0.0183
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 237,974 -220 -0.09 20,121 25.33 0.0146
2019-11-08 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 238,194 67,113 39.23 16,054 9.57 0.0127
2019-08-12 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 171,081 21,755 14.57 14,652 10.46 0.0118
2019-05-13 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 149,326 4,756 3.29 13,265 7.75 0.0128
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 144,570 14,874 11.47 12,311 -2.12 0.0125
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 129,696 4,189 3.34 12,578 6.39 0.0112
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 125,507 90,255 256.03 11,823 313.68 0.0109
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 35,252 -10,254 -22.53 2,858 -29.57 0.0024
2018-02-12 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 45,506 12,723 38.81 4,058 33.05 0.0033
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,783 -59,738 -64.57 3,050 -63.70 0.0025
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 92,521 28,379 44.24 8,403 49.25 0.0076
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 64,142 -115,369 -64.27 5,630 -62.14 0.0050
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 179,511 126,342 237.62 14,871 202.26 0.0134
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 53,169 6,348 13.56 4,920 35.09 0.0046
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 46,821 -21,902 -31.87 3,642 -35.76 0.0037
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 68,723 -1,929 -2.73 5,669 -23.41 0.0064
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 70,652 -55,871 -44.16 7,402 -44.45 0.0074
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 126,523 -5,819 -4.40 13,326 -26.38 0.0125
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 132,342 50,516 61.74 18,102 77.52 0.0161
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 81,826 31,251 61.79 10,197 123.08 0.0099
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 50,575 -59,417 -54.02 4,571 -42.41 0.0041
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 109,992 31,496 40.12 7,937 62.54 0.0069
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 78,496 47,245 151.18 4,883 129.14 0.0047
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,251 6,054 24.03 2,131 20.40 0.0022
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,197 -20,442 -44.79 1,770 -46.31 0.0016
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 45,639 18,160 66.09 3,297 114.93 0.0031
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 27,479 27,479 1,534 0.0015
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 30,000 0.00 1,695 -4.94 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 30,000 9,900.00 1,783 11,037.50 n/a n/a n/a
2025-11-10 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 300 0.00 16 0.00 n/a n/a n/a
2025-08-11 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 300 -99.01 16 -99.25 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 30,300 -44.30 2,142 -40.11 n/a n/a n/a
2025-02-12 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 54,400 99.27 3,576 86.39 n/a n/a n/a
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 27,300 -9.00 1,919 -22.32 n/a n/a n/a
2024-08-12 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 30,000 2,470 n/a n/a n/a
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 32,500 -49.38 2,876 -48.33 n/a n/a n/a
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 32,500 2,876 n/a n/a n/a
2023-08-10 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 64,200 -52.44 5,565 -57.61 n/a n/a n/a
2023-05-11 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 135,000 62.06 13,127 52.29 n/a n/a n/a
2023-02-09 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 83,300 138.00 8,621 190.53 n/a n/a n/a
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 35,000 2,967 n/a n/a n/a
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 34,800 -85.19 2,683 -87.08 n/a n/a n/a
2022-02-10 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 235,000 20,762 n/a n/a n/a
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 62,100 -14.81 5,446 -1.80 n/a n/a n/a
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 72,900 307.26 5,546 151.18 n/a n/a n/a
2020-08-12 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 17,900 -16.74 2,208 21.52 n/a n/a n/a
2020-05-12 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 21,500 -36.95 1,817 -36.98 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 34,100 -47.05 2,883 -33.59 n/a n/a n/a
2019-11-08 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 64,400 -21.08 4,341 -37.89 n/a n/a n/a
2019-08-12 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 81,600 151.08 6,989 142.09 n/a n/a n/a
2019-05-13 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 32,500 -14.92 2,887 -11.25 n/a n/a n/a
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 38,200 5.23 3,253 -7.59 n/a n/a n/a
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 36,300 153.85 3,520 161.32 n/a n/a n/a
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 14,300 -20.11 1,347 -7.17 n/a n/a n/a
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 17,900 -39.12 1,451 -44.66 n/a n/a n/a
2018-02-12 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 29,400 9.70 2,622 5.09 n/a n/a n/a
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 26,800 -27.57 2,495 -25.74 n/a n/a n/a
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 37,000 -64.56 3,360 -63.33 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 104,400 55.13 9,164 64.38 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 67,300 72.12 5,575 54.09 n/a n/a n/a
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 39,100 -22.73 3,618 -8.10 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 50,600 301.59 3,937 278.92 n/a n/a n/a
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 12,600 -16.00 1,039 -33.86 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 15,000 -88.05 1,571 -88.11 n/a n/a n/a
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 125,500 9.89 13,218 -15.38 n/a n/a n/a
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 114,200 2,986.49 15,620 3,288.29 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 3,700 -96.55 461 -94.05 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 107,300 189.22 7,749 274.35 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 37,100 2,070 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 0.00 1,695 -4.94 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 1,783 n/a n/a n/a
2025-08-11 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 0.00 2,121 7.56 n/a n/a n/a
2025-02-12 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 74.42 1,972 63.16 n/a n/a n/a
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 17,200 -42.67 1,209 -51.07 n/a n/a n/a
2024-08-12 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 2,470 n/a n/a n/a
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 35,000 0.00 3,097 2.08 n/a n/a n/a
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 35,000 3,097 n/a n/a n/a
2023-08-10 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 35,000 16.67 3,034 3.98 n/a n/a n/a
2023-05-11 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 50.00 2,917 40.99 n/a n/a n/a
2023-02-09 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 20,000 -33.33 2,070 -18.64 n/a n/a n/a
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 -25.00 2,543 -23.29 n/a n/a n/a
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 40,000 3,315 n/a n/a n/a
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 94,600 -0.11 8,295 15.13 n/a n/a n/a
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 94,700 0.85 7,205 -37.79 n/a n/a n/a
2020-08-12 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 93,900 -6.85 11,582 35.97 n/a n/a n/a
2020-05-12 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 100,800 26.00 8,518 25.93 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 80,000 9.59 6,764 37.48 n/a n/a n/a
2019-11-08 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 73,000 27.40 4,920 0.24 n/a n/a n/a
2019-08-12 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 57,300 15.76 4,908 11.62 n/a n/a n/a
2019-05-13 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 49,500 7.61 4,397 12.25 n/a n/a n/a
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 46,000 7.23 3,917 -5.84 n/a n/a n/a
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 42,900 -15.22 4,160 -12.73 n/a n/a n/a
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 50,600 9.52 4,767 27.29 n/a n/a n/a
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 46,200 -24.39 3,745 -31.27 n/a n/a n/a
2018-02-12 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 61,100 -21.67 5,449 -24.93 n/a n/a n/a
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 78,000 -52.15 7,259 -50.96 n/a n/a n/a
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 163,000 95.21 14,803 101.98 n/a n/a n/a
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 83,500 -0.24 7,329 5.70 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 83,700 -21.85 6,934 -30.02 n/a n/a n/a
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 107,100 145.08 9,909 191.44 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 43,700 21.73 3,400 14.83 n/a n/a n/a
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 35,900 -8.42 2,961 -27.90 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 39,200 -73.99 4,107 -74.12 n/a n/a n/a
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 150,700 29.25 15,872 -0.48 n/a n/a n/a
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 116,600 847.97 15,949 940.38 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 12,300 1,533 n/a n/a n/a
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 30,000 2,165 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.